Pulmonx Corp is a commercial-stage medical technology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LUNG is expected to report earnings to rise 15.26% to -39 cents per share on February 25
Q4'25
Est.
$-0.39
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.12
The last earnings report on November 12 showed earnings per share of -34 cents, beating the estimate of -41 cents. With 1.34M shares outstanding, the current market capitalization sits at 80.27M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LUNG showed earnings on November 12, 2025. You can read more about the earnings report here.